These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 16137837)

  • 1. A phase III randomized, placebo-controlled, double-blind study of misoprostol rectal suppositories to prevent acute radiation proctitis in patients with prostate cancer.
    Hille A; Schmidberger H; Hermann RM; Christiansen H; Saile B; Pradier O; Hess CF
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1488-93. PubMed ID: 16137837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective randomized placebo-controlled double-blinded pilot study of misoprostol rectal suppositories in the prevention of acute and chronic radiation proctitis symptoms in prostate cancer patients.
    Khan AM; Birk JW; Anderson JC; Georgsson M; Park TL; Smith CJ; Comer GM
    Am J Gastroenterol; 2000 Aug; 95(8):1961-6. PubMed ID: 10950043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients.
    Jahraus CD; Bettenhausen D; Malik U; Sellitti M; St Clair WH
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1483-7. PubMed ID: 16099600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a prostaglandin--given rectally for prevention of radiation-induced acute proctitis--on late rectal toxicity. Results of a phase III randomized, placebo-controlled, double-blind study.
    Kertesz T; Herrmann MK; Zapf A; Christiansen H; Hermann RM; Pradier O; Schmidberger H; Hess CF; Hille A
    Strahlenther Onkol; 2009 Sep; 185(9):596-602. PubMed ID: 19756426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral sucralfate on late rectal injury associated with radiotherapy for prostate cancer: A double-blind, randomized trial.
    Kneebone A; Mameghan H; Bolin T; Berry M; Turner S; Kearsley J; Graham P; Fisher R; Delaney G
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1088-97. PubMed ID: 15519779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sucralfate versus mesalazine versus hydrocortisone in the prevention of acute radiation proctitis during conformal radiotherapy for prostate carcinoma. A randomized study.
    Sanguineti G; Franzone P; Marcenaro M; Foppiano F; Vitale V
    Strahlenther Onkol; 2003 Jul; 179(7):464-70. PubMed ID: 12835883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily sodium butyrate enema for the prevention of radiation proctitis in prostate cancer patients undergoing radical radiation therapy: results of a multicenter randomized placebo-controlled dose-finding phase 2 study.
    Maggio A; Magli A; Rancati T; Fiorino C; Valvo F; Fellin G; Ricardi U; Munoz F; Cosentino D; Cazzaniga LF; Valdagni R; Vavassori V
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):518-24. PubMed ID: 24803033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can we decrease the acute proctitis in prostate cancer patients using hyaluronic acid during radiation therapy: a prospective historically controlled clinical study.
    Stefanelli A; Pascale G; Rainieri E; Ursino S; Colella M; Zini G; Berretta M; Fiorica F
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):639-45. PubMed ID: 22774405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis.
    Hille A; Christiansen H; Pradier O; Hermann RM; Siekmeyer B; Weiss E; Hilgers R; Hess CF; Schmidberger H
    Strahlenther Onkol; 2005 Sep; 181(9):606-14. PubMed ID: 16170489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Unwanted side-effects in using mesalazine (5-aminosalicylic acid) during radiotherapy].
    Freund U; Schölmerich J; Siems H; Kluge F; Schäfer HE; Wannenmacher M
    Strahlenther Onkol; 1987 Oct; 163(10):678-80. PubMed ID: 3313776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
    Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
    Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
    Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage.
    Heemsbergen WD; Peeters ST; Koper PC; Hoogeman MS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):3-10. PubMed ID: 16814954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal complications of external beam radiation versus brachytherapy for prostate cancer.
    Lesperance RN; Kjorstadt RJ; Halligan JB; Steele SR
    Am J Surg; 2008 May; 195(5):616-20; discussion 620. PubMed ID: 18374892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amifostine as radioprotective agent for the rectal mucosa during irradiation of pelvic tumors. A phase II randomized study using various toxicity scales and rectosigmoidoscopy.
    Kouvaris J; Kouloulias V; Malas E; Antypas C; Kokakis J; Michopoulos S; Matsopoulos G; Vlahos L
    Strahlenther Onkol; 2003 Mar; 179(3):167-74. PubMed ID: 12627259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase III double-blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis.
    O'Brien PC; Franklin CI; Dear KB; Hamilton CC; Poulsen M; Joseph DJ; Spry N; Denham JW
    Radiother Oncol; 1997 Nov; 45(2):117-23. PubMed ID: 9424000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of oral sucralfate on the acute proctitis associated with prostate radiotherapy: a double-blind, randomized trial.
    Kneebone A; Mameghan H; Bolin T; Berry M; Turner S; Kearsley J; Graham P; Fisher R; Delaney G
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):628-35. PubMed ID: 11597802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C.
    Kennedy M; Bruninga K; Mutlu EA; Losurdo J; Choudhary S; Keshavarzian A
    Am J Gastroenterol; 2001 Apr; 96(4):1080-4. PubMed ID: 11316150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing measures of acute bowel toxicity in patients with prostate cancer treated with external beam radiation therapy.
    Muanza TM; Albert PS; Smith S; Godette D; Crouse NS; Cooley-Zgela T; Sciuto L; Camphausen K; Coleman CN; Ménard C
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1316-21. PubMed ID: 16029787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.